Clinical Study | Office of Clinical Research

Platelet-Oriented Inhibition In New Tia And Minor Ischemic Stroke (Point) Trial

Posted Date: May 15, 2019

Investigator: Kyle Walsh
Type of Study: Drug

The purpose of this research study is to determine the safety and effectiveness of the combination of low-dose aspirin and a medication called clopidogrel (also known by the brand name Plavix?) in reducing the risk of stroke, heart attacks and other complications in patients who have just had a t

Criteria:

You Are Being Asked To Take Part In This Research Study Because You Are 18 Years Of Age Or Older An

Keywords:

Emergency Medicine, Stroke

For More Information:

Irene Ewing
(513) 558-3450
ewingi@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List